Related Experiment Video
Updated: Apr 11, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Survival in cats with primary and secondary cardiomyopathies
Ilaria Spalla1, Chiara Locatelli2, Giulia Riscazzi2
1The Cardiology Unit; Department of Veterinary Sciences and Public Health (DIVET), Università degli Studi di Milano, Milan, Italy illispa@hotmail.com.
Insights
Feline cardiomyopathies (CMs) vary in survival outcomes, with hypertrophic cardiomyopathy (HCM) having the longest median survival. Clinical signs and specific echocardiographic markers predict poor prognosis across all feline CM types.
Area of Science:
- Veterinary Cardiology
- Comparative Pathology
Background:
- Feline cardiomyopathies (CMs) are diverse myocardial diseases, with hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM) being common.
- Limited data exists comparing outcomes for different feline CM types and the impact of systemic diseases on survival.
Purpose of the Study:
- To compare survival times and identify prognostic factors in cats with HCM, RCM, or secondary CM.
- To investigate cardiovascular consequences of systemic diseases on feline survival.
Main Methods:
- Retrospective study of 94 cats with complete records and echocardiography.
- Categorization into HCM (50 cats), RCM (14 cats), and secondary CM (30 cats).
Main Results:
- Significant survival differences observed: HCM (865 days), RCM (273 days), secondary CM (<50% cardiac death rate).
- Independent risk factors for poor prognosis included clinical signs, elevated left atrial to aortic root (LA/Ao) ratio, and hypercoagulable state.
- Primary CMs (HCM + RCM) share features like LA dimension and hypercoagulability affecting survival.
Conclusions:
- Clinical signs and LA/Ao ratio are critical indicators of severity in feline CM.
- While secondary CMs are generally more benign, poor management of the underlying systemic disease can lead to adverse outcomes.
- Understanding shared feline cardiovascular physiology is key to managing end-stage CM.
Objectives:
Feline cardiomyopathies (CMs) represent a heterogeneous group of myocardial diseases. The most common CM is hypertrophic cardiomyopathy (HCM), followed by restrictive cardiomyopathy (RCM). Studies comparing survival and outcome for different types of CM are scant. Furthermore, little is known about the cardiovascular consequences of systemic diseases on survival. The aim of this retrospective study was to compare survival and prognostic factors in cats affected by HCM, RCM or secondary CM referred to our institution over a 10 year period.
Methods:
The study included 94 cats with complete case records and echocardiographic examination. Fifty cats presented HCM, 14 RCM and 30 secondary CM.
Results:
A statistically significant difference in survival time was identified for cats with HCM (median survival time of 865 days), RCM (273 days) and secondary CM (<50% cardiac death rate). In the overall population and in the primary CM group (HCM + RCM), risk factors in the multivariate analysis, regardless of the CM considered, were the presence of clinical signs, an increased left atrial to aortic root (LA/Ao) ratio and a hypercoagulable state.
Conclusions And Relevance:
Primary CMs in cats share some common features (ie, LA dimension and hypercoagulable state) linked to feline cardiovascular physiology, which influence survival greatly in end-stage CM. The presence of clinical signs has to be regarded as a marker of disease severity, regardless of the underlying CM. Secondary CMs are more benign conditions, but if the primary disease is not properly managed, the prognosis might also be poor in this group of patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

